A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multi-Center, Parallel Group Study to evaluate Efficacy and Safety of GK664S in Subjects with moderate-to-severe scalp Seborrheic dermatitis.
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multi-Center, Parallel Group Study to evaluate Efficacy and Safety of GK664S in Subjects with moderate-to-severe scalp Seborrheic dermatitis.
A Open-Label Phase 3, Multi-Center, Parallel Group Study to evaluate Efficacy and Safety Study of GK664S in Subjects with moderate-to-severe scalp Eczema Dermatitis except for seborrheic dermatitis.